Functional and structural characterization of soluble recombinant epsilon toxin of Clostridium perfringens D, causative agent of enterotoxaemia

Applied Microbiology and Biotechnology

Volumn 88, Issue 4, 2010, Pages 877-884

  Mathur, Deepika Dayal ^a   Deshmukh, Sachin ^a   Kaushik, Himani ^a   Garg, Lalit C ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Clostridium perfringens; Enterotoxaemia .MDCK cells; Epsilon toxin

Indexed keywords

ANION EXCHANGE CHROMATOGRAPHY; BIOLOGICAL ACTIVITIES; CAUSATIVE AGENTS; CLOSTRIDIUM PERFRINGENS; CYTOTOXIC; ECONOMIC CONCERNS; ENTEROTOXAEMIA .MDCK CELLS; EPSILON TOXIN; EPSILON TOXINS; HEPTAMERS; MADIN-DARBY CANINE KIDNEY CELLS; MDCK CELLS; MOUSE BRAIN; SOLUBLE PROTEINS; STRUCTURAL CHARACTERIZATION; WESTERN BLOTTING;

ANTIGENS; BIOACTIVITY; CLOSTRIDIUM; ESCHERICHIA COLI; MONOCLONAL ANTIBODIES; PURIFICATION;

TOXIC MATERIALS;

BACTERIAL TOXIN; BACTERIAL VACCINE; GENOMIC DNA; RECOMBINANT EPSILON TOXIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; CLOSTRIDIUM PERFRINGENS EPSILON TOXIN; CLOSTRIDIUM PERFRINGENS EPSILON-TOXIN; RECOMBINANT PROTEIN;

ANTIBODY; ANTIGEN; BACTERIUM; CATTLE; HOMOGENEITY; MORTALITY; PATHOGEN; TOXIN; VACCINE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BACTERIAL STRAIN; CELL MEMBRANE; CELL STRAIN; CELL VIABILITY; CIRCULAR DICHROISM; CLOSTRIDIUM; CLOSTRIDIUM PERFRINGENS TYPE D; CYTOTOXICITY TEST; DRUG DESIGN; ENTEROTOXEMIA; ESCHERICHIA COLI; FLOW CYTOMETRY; NONHUMAN; PLASMID; PROTEIN EXPRESSION; PROTEIN PURIFICATION; THERMOSTABILITY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL LINE; CLOSTRIDIUM PERFRINGENS; DOG; IMMUNOLOGY; METABOLISM; MOUSE; SYNAPTOSOME;

BOS; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM PERFRINGENS D; ESCHERICHIA COLI;

ANIMALS; BACTERIAL TOXINS; BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE; CLOSTRIDIUM PERFRINGENS; DOGS; ESCHERICHIA COLI; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SYNAPTOSOMES;

EID: 79952110947     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-010-2785-y     Document Type: Article

References (28)

1. Cole AR, Gibert M, Popoff MR, Moss DS, Titball RW, Basak AK (2004) Clostridium perfringens epsilon-toxin shows structural similarity to the pore-forming toxin aerolysin. Nat Struct Mol Biol 11:797-798 (Pubitemid 39014507)
2. Gardner DE (1973) Pathology of Clostridium welchii type D enterotoxaemia. II. Structural and ultrastructural alterations in the tissues of lambs and mice. J Comp Pathol 83:509-524
3. Goswami PP, Rupa P, Prihar NS, Garg LC (1996) Molecular cloning of Clostridium perfringens epsilon-toxin gene and its high level expression in E coli. Biochem Biophys Res Commun 226:735-740 (Pubitemid 26348541)
4. Habeeb AF, Lee CL, Atassi MZ (1973) Conformational studies on modified proteins and peptides. VII. Conformation of epsilonprototoxin and epsilon-toxin from Clostridium perfringens. Conformational changes associated with toxicity. Biochim Biophys Acta 322:245-250
5. Hildebrand A, Pohl M, Bhakdi S (1991) Staphylococcus aureus a- toxin. Dual mechanism of binding to target cells. J Biol Chem 266:17195-17200 (Pubitemid 21907924)
6. Hunter SE, Clarke IN, Kelly DC, Titball RW (1992) Cloning and nucleotide sequencing of the Clostridium perfringens epsilontoxin gene and its expression in Escherichia coli. Infect Immun 60:102-110
7. Knapp O, Maier E, Benz R, Geny B, Popoff MR (2009) Identification of the channel-forming domain of Clostridium perfringens Epsilon-toxin (ETX). Biochim Biophys Acta 1788:2584-2593
8. Laemmli UK (1970) Cleavage of structural proteins using the assembly of the head of bacteriophage T4. Nature 227:680-685
9. Liu DT (1992) Deamidation: A source of microheterogeneity in pharmaceutical proteins. Trends Biotechnol 10:364-369
10. McClane BA, Chakrabarti G (2004) New insights into the cytotoxic mechanisms of Clostridium perfringens enterotoxin. Anaerobe 10:107-114 (Pubitemid 38519811)
11. Nagahama M, Sakurai J (1992) High-affinity binding of Clostridium perfringens epsilon toxin to rat brain. Infect Immun 60:1237-1240
12. Nakano M, Kawano Y, Kawagish M, Hasegawa T, Linuma Y, Oht M (2002) Two-dimensional analysis of exoproteins of methicillinresistant Staphylococcus aureus for possible epidemiological applications. Microbiol Immunol 46:11-22 (Pubitemid 34101082)
13. Ohri S, Sharma D, Dixit A (2004) Interaction of an approximately 40 kDa protein from regenerating rat liver with the -148 to -124 region of c-jun complexed with RLjunRP coincides with enhanced c-jun expression in proliferating rat liver. Eur J Biochem 271:4892-4902 (Pubitemid 40065592)
14. Parker MW, Feil SC (2005) Pore-forming protein toxins: From structure to function. Prog Biophys Mol Biol 88:91-142 (Pubitemid 39547775)
15. Payne DW, Williamson ED, Harvard H, Modi N, Brown J (1994) Evaluation of a new cytotoxicity assay for Clostridium perfringens type D epsilon toxin. FEMS Microbiol Lett 116:161-168 (Pubitemid 24069292)
16. Perkins M, Theiler R, Lunte S, Jeschke M (2000) Determination of the origin of charge heterogeneity in a murine monoclonal antibody. Pharm Res 17:1110-1117
17. Petit L, Gibert M, Gillet D, Popoff MR (1997) Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex. J Bacteriol 179:6480-6487 (Pubitemid 27443933)
18. Petit L, Maier E, Gibert M, Popoff MR, Benz R (2001) Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers. J Biol Chem 276:15736-15740
19. Promodonkoy B, Ellar DJ (2003) Investigation of the pore-forming mechanism of a cytolytic delta-endotoxin from Bacillus thuringiensis. Biochem J 374:255-259 (Pubitemid 37046950)
20. Sakurai J, Nagahama M (1987) Carboxyl groups in Clostridium perfringens epsilon toxin. Microb Pathog 3:469-474 (Pubitemid 18029280)
21. Sellman BR, Tweten RK, Kagan BL (1997) Generation of a membrane bound pre-pore complex is necessary for poreformation by C. perfringens alpha-toxin. Mol Microbiol 25:429-440
22. Soler-Jover A, Dorca J, Popoff MR, Gibert M, Saura J, Tusell JM, Serratosa J, Blasi J, Martín-Satué M (2007) Distribution of Clostridium perfringens epsilon toxin in the brains of acutely intoxicated mice and its effect upon glial cells. Toxicon 50:530-540 (Pubitemid 47368587)
23. Steinthorsdottir V, Halldorsson H, Andresson OS (2000) Clostridium perfringens beta-toxin forms multimeric transmembrane pores in human endothelial cells. Microb Pathog 28:45-50 (Pubitemid 30037815)
24. Tamai E, Inida T, Matsushita O, Suda O, Sonobe H, Okabe A (2003) Accumulation of Clostridium perfringens epsilon-toxin in the mouse kidney and its possible biological significance. Infect Immun 71:5371-5375 (Pubitemid 37070786)
25. Thomson RO (1962) Crystalline epsilon-prototoxin from Clostridium welchii. Nature 193:69-70
26. Titball RW (2009) Clostridium perfringens vaccines. Vaccine 27 (suppl 4):D44-D47
27. Worthington RW, Mulders MSG (1977) Physical changes in the epsilon prototoxin molecule of Clostridium perfringens during enzymatic activation. Infect Immun 18:549-551 (Pubitemid 8231936)
28. Zhu C, Ghabriel MN, Blumbergs DC, Reilly PL, Manavis J, Youssef J, Hatami S, Finnie JW (2001) Clostridium perfringens prototoxin-induced alteration of endothelial barrier antigen (EBA) immunoreactivity at the blood-brain barrier (BBB). Exp Neurol 169:72-82 (Pubitemid 32424324)